Truvvo Partners’s Celgene Corp CELG Stock Holding History

Truvvo Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,900	Closed	-$390K	–	151
2016 Q1	$390K	Buy	+3,900	New	+$402K	0.18%	100

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Truvvo Partners's CELG Position: Q2 2016 in Review

Truvvo Partners sold out of Celgene Corp (CELG) in Q2 2016, closing a stake of 3,900 shares — an estimated $390K sold.

Truvvo Partners first reported a position in CELG in Q1 2016 and held it in 1 quarter. The position peaked at $390K in Q1 2016. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

Truvvo Partners reported no remaining Celgene Corp position as of Q2 2016 after selling out during the quarter.
Truvvo Partners sold 3,900 Celgene Corp shares in Q2 2016, an estimated $390K.
Truvvo Partners first reported a position in Celgene Corp in Q1 2016 and held it in 1 quarter.
Truvvo Partners's Celgene Corp position peaked at $390K in Q1 2016.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on Truvvo Partners's 13F filing for Q2 2016, filed 9 Aug 2016.